Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$801,374
-$123,067 QoQ
Shares Held
6,343
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,169
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. GILD ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $801,374 | 6,343 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $924,441 | 6,633 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $798,423 | 6,505 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $688,644 | 6,204 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $641,715 | 5,788 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $612,913 | 5,470 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $519,027 | 5,619 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $704,759 | 8,406 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $570,629 | 8,317 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $605,924 | 8,272 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $539,364 | 6,658 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $493,554 | 6,586 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $469,818 | 6,096 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $497,902 | 6,001 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,144,618 | 24,981 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,636,080 | 26,521 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,607,739 | 26,011 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,541,122 | 25,923 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,279,896 | 17,627 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,231,245 | 17,627 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,222,609 | 17,755 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,162,370 | 17,985 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,179,531 | 20,246 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,280,545 | 20,265 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,203,187 | 15,638 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,464,697 | 19,592 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||